{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T20:57:48Z","timestamp":1769979468580,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01NS078307"],"award-info":[{"award-number":["R01NS078307"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01NS43284"],"award-info":[{"award-number":["R01NS43284"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R41MH093302"],"award-info":[{"award-number":["R41MH093302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21NS077236"],"award-info":[{"award-number":["R21NS077236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R42MH093302"],"award-info":[{"award-number":["R42MH093302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21HD057256"],"award-info":[{"award-number":["R21HD057256"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientist Development Grant"},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["13SDG13950015"],"award-info":[{"award-number":["13SDG13950015"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000874","name":"Brain Behavior Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.nbd.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T03:47:27Z","timestamp":1374378447000},"page":"206-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Intracellular and circulating neuronal antinuclear antibodies in human epilepsy"],"prefix":"10.1016","volume":"59","author":[{"suffix":"II","given":"Philip H.","family":"Iffland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Carvalho-Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Trigunaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitali","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damir","family":"Janigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.07.006_bb0005","first-page":"144","article-title":"Arterial vascular abnormality accompanying cerebral cortical dysplasia","volume":"18","author":"Abe","year":"1997","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eplepsyres.2012.04.005","article-title":"Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: a population-based case\u2013control study","volume":"101","author":"Adelow","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2013.07.006_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.it.2010.06.006","article-title":"B cells and autoantibodies: complex roles in CNS injury","volume":"31","author":"Ankeny","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2006.11.007","article-title":"What is the blood\u2013brain barrier (not)?","volume":"28","author":"Bechmann","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0025","series-title":"Epilepsy: A Comprehensive Textbook","first-page":"89","article-title":"Epidemiology in developing countries","author":"Bharucha","year":"2008"},{"key":"10.1016\/j.nbd.2013.07.006_bb0030","first-page":"208","article-title":"Lupus-like syndrome and vasculitis induced by valpromide","volume":"30","author":"Bonnet","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.nbd.2013.07.006_bb9020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1172\/JCI117305","article-title":"The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus","volume":"94","author":"Burlingame","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2013.07.006_bb0035","article-title":"Lamotrigine-induced lupus-like syndrome: a case report and literature review","author":"Chang","year":"2012","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.nbd.2013.07.006_bb0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.nbd.2013.07.006_bb0045","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1523\/JNEUROSCI.2323-09.2009","article-title":"Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?","volume":"29","author":"David","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.07.006_bb0050","first-page":"86","article-title":"Astrocytic potassium and glutamate buffering controls synaptic responses in a frequency-dependent manner","volume":"50","author":"David","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03702.x","article-title":"Inflammatory events at blood\u2013brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease","volume":"53","author":"de Vries","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0013-4694(98)00036-4","article-title":"The photic driving EEG response and photoreactive cerebral blood flow in the posterior cerebral artery in controls and in patients with epilepsy","volume":"107","author":"Diehl","year":"1998","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-1211(01)00273-X","article-title":"High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases","volume":"46","author":"Eriksson","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2013.07.006_bb0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte\u2013endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2013.07.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2012.12.005","article-title":"Basic mechanisms of catastrophic epilepsy \u2014 overview from animal models","author":"Galanopoulou","year":"2013","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2013.07.006_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0085","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1523\/JNEUROSCI.1901-08.2008","article-title":"Postnatal inflammation increases seizure susceptibility in adult rats","volume":"28","author":"Galic","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.07.006_bb0095","first-page":"1.276","article-title":"Steroid treatment is effective in the treatment of status epilepticus in children","author":"Granata","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1167.2011.03029.x","article-title":"Immune-mediated epilepsies","volume":"52","author":"Granata","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1474-4422(11)70280-0","article-title":"CNS autoimmunity: new findings and pending issues","volume":"11","author":"Graus","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2013.07.006_bb9015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4049\/jimmunol.1200993","article-title":"Immunodeficiency and autoimmunity in H2-O-deficient mice","volume":"190","author":"Gu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5414\/NP300545","article-title":"Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of anti-neuronal antibodies","volume":"31","author":"Hoftberger","year":"2012","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.nbd.2013.07.006_bb9005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2249.1990.tb05483.x","article-title":"Temporary breakdown of immunological tolerance to dsDNA and nucleohistone antigens in rabbits infected with rinderpest virus","volume":"82","author":"Imaoka","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00415-009-5384-z","article-title":"Blood\u2013brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome","volume":"257","author":"Ivens","year":"2010","journal-title":"J. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2013.07.006_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03472.x","article-title":"Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood\u2013brain barrier","volume":"53","author":"Janigro","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2407-6-72","article-title":"Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells","volume":"6","author":"Janigro","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nbd.2013.07.006_bb0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2014pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00019052-200306000-00016","article-title":"New autoantibody mediated disorders of the central nervous system","volume":"16","author":"Lang","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0135","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1586\/14737175.8.7.1141","article-title":"Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis","volume":"8","author":"Levite","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.nbd.2013.07.006_bb0140","first-page":"2290","article-title":"An exploratory study of ferumoxtran-10 nanoparticles as a blood\u2013brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions","volume":"26","author":"Manninger","year":"2005","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-2-37","article-title":"Significance of MDR1 and multiple drug resistance in refractory human epileptic brain","volume":"2","author":"Marchi","year":"2004","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.nbd.2013.07.006_bb0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","article-title":"Seizure-promoting effect of blood\u2013brain barrier disruption","volume":"48","author":"Marchi","year":"2007","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.nbd.2013.07.006_bb0190","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1528-1167.2007.01185.x","article-title":"In vivo and in vitro effects of pilocarpine: relevance to epileptogenesis","volume":"48","author":"Marchi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2008.10.002","article-title":"Antagonism of peripheral inflammation reduces the severity of status epilepticus","volume":"33","author":"Marchi","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.07.006_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.2009.225","article-title":"Transporters in drug-refractory epilepsy: clinical significance","volume":"87","author":"Marchi","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2013.07.006_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018200","article-title":"Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics","volume":"6","author":"Marchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2013.07.006_bb0165","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1093\/brain\/awr343","article-title":"The blood\u2013brain barrier hypothesis in drug resistant epilepsy","volume":"135","author":"Marchi","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.07.006_bb0175","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood\u2013brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0185","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1167.2011.03080.x","article-title":"Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures","volume":"52","author":"Marchi","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0195","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.07.006_bb0200","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/NEN.0b013e31826809a6","article-title":"IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood\u2013brain barrier disruption","volume":"71","author":"Michalak","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.nbd.2013.07.006_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1528-1167.2012.03614.x","article-title":"Autoimmune and inflammatory epilepsies","volume":"53","author":"Nabbout","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1474-4422(10)70214-3","article-title":"Acute encephalopathy with inflammation-mediated status epilepticus","volume":"10","author":"Nabbout","year":"2011","journal-title":"Lancet Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2013.07.006_bb0215","first-page":"S27","article-title":"Definition of the epileptogenic zone in a patient with non-lesional temporal lobe epilepsy arising from the dominant hemisphere","volume":"8","author":"Najm","year":"2006","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.nbd.2013.07.006_bb0220","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0002-9343(00)00617-3","article-title":"Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders","volume":"109","author":"Peltola","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.nbd.2013.07.006_bb0225","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/AD8R-560C-4V11-C5E2","article-title":"Rasmussen encephalitis: a clinicopathologic and immunohistochemical study of seven patients","volume":"117","author":"Prayson","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2003.12.004","article-title":"Anticardiolipin and antinuclear antibodies in epilepsy\u2014a population-based cross-sectional study","volume":"58","author":"Ranua","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2013.07.006_bb0235","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/brain\/awm118","article-title":"Angiogenesis is associated with blood\u2013brain barrier permeability in temporal lobe epilepsy","volume":"130","author":"Rigau","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.07.006_bb0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","article-title":"The sterile inflammatory response","volume":"28","author":"Rock","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0245","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2125.2010.03733.x","article-title":"Do selected drugs increase the risk of lupus? A matched case\u2013control study","volume":"70","author":"Schoonen","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0250","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1523\/JNEUROSCI.1751-04.2004","article-title":"Lasting blood\u2013brain barrier disruption induces epileptic focus in the rat somatosensory cortex","volume":"24","author":"Seiffert","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.07.006_bb9010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08916930701352357","article-title":"Multiple specificities of autoantibodies against hnRNP A\/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen","volume":"40","author":"Siapka","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.nbd.2013.07.006_bb0255","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1227\/01.NEU.0000210248.39504.B5","article-title":"Ultrastructure of perinidal capillaries in cerebral arteriovenous malformations","volume":"58","author":"Tu","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2013.07.006_bb0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuroscience.2007.10.037","article-title":"Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood\u2013brain barrier permeability","volume":"151","author":"Uva","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.07.006_bb9000","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.2010.129320","article-title":"Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus","volume":"70","author":"Van Bavel","year":"2011","journal-title":"Anns. Rheum. Dis."},{"key":"10.1016\/j.nbd.2013.07.006_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1528-1167.2011.03242.x","article-title":"Therapeutic potential of new antiinflammatory drugs","volume":"52","author":"Vezzani","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.07.006_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-444-52898-8.00010-0","article-title":"Inflammation and epilepsy","volume":"107","author":"Vezzani","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2013.07.006_bb0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2006.09.024","article-title":"Autoimmune channelopathies and related neurological disorders","volume":"52","author":"Vincent","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.07.006_bb0280","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1997.86.2.0226","article-title":"Cerebral blood flow and temporal lobe epileptogenicity","volume":"86","author":"Weinand","year":"1997","journal-title":"J. Neurosurg."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T12:20:05Z","timestamp":1539519605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":60,"alternative-id":["S0969996113002003"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.07.006","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular and circulating neuronal antinuclear antibodies in human epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2013.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}